Compounded Bioidentical Hormone Therapy: The National Academies Weigh In

The overarching conclusion of US National Academies of Sciences, Engineering, and Medicine committee is that given the paucity of data on safety and effectiveness, there is insufficient evidence to support use of compounded bioidentical hormone therapy as treatment for menopause.

Source:

JAMA Internal Medicine